- The rising prevalence of autoimmune disorders, immune deficiency disorders, bleeding disorders as well as increasing adoption of plasma protein therapy in neurology and other therapeutic
- Growing R&D investments in plasma-derived therapies to bridge gap of novel therapeutics for autoimmune and acute inflammatory conditions - Massive clinical demand for intravenous immunoglobulin